Torrent Pharmaceuticals Ltd

Torrent Pharma. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Torrent Pharmaceuticals Ltd

₹ 3,375 0.74%
11 Dec 3:51 p.m.
torrentpharma.com BSE: 500420 NSE: TORNTPHARM
About

Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.[1]

It is the flagship company of Torrent Group which also has presence in power and city gas distribution businesses.[2]

Key Points

Product Offerings
The company manufactures pharmaceutical products under various dosage forms such as oral solids, oral liquids, topicals, suppositories, Human insulin and synthetic APIs. API manufacturing is predominantly aimed at captive consumption.[1]

Website BSE NSE
  • Market Cap ₹ 1,14,215 Cr.
  • Current Price ₹ 3,375
  • High / Low ₹ 3,591 / 2,025
  • Stock P/E 65.6
  • Book Value ₹ 222
  • Dividend Yield 0.83 %
  • ROCE 23.2 %
  • ROE 24.2 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company has been maintaining a healthy dividend payout of 73.8%
  • Company's working capital requirements have reduced from 72.1 days to 53.1 days

Cons

  • Stock is trading at 15.2 times its book value
  • The company has delivered a poor sales growth of 6.93% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Part of BSE 100 LargeCap TMC Index BSE Dollex 200 BSE MidCap Nifty100 ESG Nifty 500 Multicap 50:25:25

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
2,137 2,108 2,131 2,347 2,291 2,491 2,491 2,591 2,660 2,732 2,745 2,859 2,889
1,477 1,570 1,570 1,635 1,612 1,767 1,764 1,800 1,835 1,863 1,862 1,955 1,950
Operating Profit 660 538 561 712 679 724 727 791 825 869 883 904 939
OPM % 31% 26% 26% 30% 30% 29% 29% 31% 31% 32% 32% 32% 32%
51 48 -429 30 16 -10 9 34 26 55 31 24 -16
Interest 71 62 57 55 69 102 107 103 91 80 80 75 64
Depreciation 168 167 162 155 163 193 196 191 201 213 203 197 198
Profit before tax 472 357 -87 532 463 419 433 531 559 631 631 656 661
Tax % 33% 30% 36% 33% 33% 30% 34% 29% 31% 30% 29% 30% 31%
316 249 -118 354 312 292 287 378 386 443 449 457 453
EPS in Rs 9.34 7.36 -3.49 10.46 9.22 8.63 8.48 11.17 11.41 13.09 13.27 13.50 13.39
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
3,203 4,172 4,636 6,687 5,816 5,950 7,673 7,939 8,005 8,508 9,620 10,728 11,225
2,506 3,216 3,616 3,954 4,438 4,601 5,690 5,769 5,524 6,077 6,778 7,360 7,630
Operating Profit 697 955 1,020 2,733 1,377 1,349 1,983 2,170 2,480 2,431 2,842 3,368 3,595
OPM % 22% 23% 22% 41% 24% 23% 26% 27% 31% 29% 30% 31% 32%
1 34 286 32 223 299 -300 121 57 -288 45 146 94
Interest 34 59 175 184 206 308 504 451 353 255 333 354 299
Depreciation 83 87 191 238 307 409 618 654 658 662 707 808 811
Profit before tax 582 844 940 2,343 1,088 931 562 1,187 1,526 1,226 1,847 2,352 2,579
Tax % 25% 21% 20% 26% 14% 27% 22% 14% 18% 37% 33% 30%
435 664 751 1,733 934 678 436 1,025 1,252 777 1,245 1,656 1,802
EPS in Rs 12.79 19.62 22.19 51.22 27.59 20.04 12.89 30.28 36.99 22.97 36.79 48.94 53.25
Dividend Payout % 45% 25% 25% 34% 25% 35% 66% 53% 47% 105% 60% 57%
Compounded Sales Growth
10 Years: 10%
5 Years: 7%
3 Years: 10%
TTM: 10%
Compounded Profit Growth
10 Years: 9%
5 Years: 22%
3 Years: 8%
TTM: 30%
Stock Price CAGR
10 Years: 20%
5 Years: 29%
3 Years: 30%
1 Year: 65%
Return on Equity
10 Years: 23%
5 Years: 21%
3 Years: 21%
Last Year: 24%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 42 85 85 85 85 85 85 85 85 85 169 169 169
Reserves 1,380 1,818 2,406 3,409 4,266 4,538 4,640 4,739 5,753 5,868 6,029 6,687 7,335
693 1,132 2,740 2,352 2,510 6,462 6,038 5,784 4,874 4,070 5,369 4,022 3,128
1,638 1,988 2,589 3,040 2,740 3,159 3,351 3,402 3,363 2,884 3,043 3,627 4,456
Total Liabilities 3,753 5,022 7,820 8,886 9,601 14,243 14,113 14,010 14,075 12,906 14,610 14,505 15,088
820 875 2,833 2,859 3,688 7,855 7,748 7,533 7,065 6,423 8,121 8,138 7,890
CWIP 285 534 678 1,042 519 647 617 712 889 630 765 361 412
Investments 60 186 298 780 804 492 353 2 181 226 199 173 127
2,587 3,427 4,011 4,206 4,589 5,249 5,395 5,763 5,940 5,628 5,524 5,834 6,659
Total Assets 3,753 5,022 7,820 8,886 9,601 14,243 14,113 14,010 14,075 12,906 14,610 14,505 15,088

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
153 599 810 2,742 1,009 894 1,798 1,393 2,005 1,803 2,368 3,266
-247 -418 -2,113 -869 -798 -4,677 -246 229 -444 -196 -2,335 -160
20 86 1,212 -1,435 -193 3,417 -1,314 -1,549 -1,651 -1,781 77 -2,780
Net Cash Flow -73 268 -90 437 18 -366 238 73 -89 -174 110 327

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 78 96 125 79 60 77 68 76 69 70 74 63
Inventory Days 364 297 275 314 318 429 318 362 456 368 298 310
Days Payable 421 421 472 523 356 447 345 345 351 250 224 284
Cash Conversion Cycle 22 -28 -71 -130 21 59 42 93 174 188 147 89
Working Capital Days 33 42 54 -1 28 20 -17 -2 82 89 74 53
ROCE % 33% 35% 27% 48% 19% 13% 13% 15% 17% 19% 20% 23%

Shareholding Pattern

Numbers in percentages

3 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
71.25% 71.25% 71.25% 71.25% 71.25% 71.25% 71.25% 71.25% 71.25% 71.25% 71.25% 71.25%
11.63% 10.88% 10.80% 11.37% 12.09% 12.04% 12.85% 13.15% 14.08% 14.14% 14.22% 14.46%
8.94% 9.74% 10.01% 9.40% 8.77% 8.89% 8.22% 7.91% 7.11% 7.15% 7.17% 6.98%
0.00% 0.00% 0.00% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10%
8.18% 8.14% 7.95% 7.87% 7.78% 7.71% 7.59% 7.59% 7.46% 7.34% 7.25% 7.21%
No. of Shareholders 67,20563,22962,93367,86665,23763,83161,57269,61269,11771,15474,76579,848

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls